Skip to content
PICO Portalanswers from OpenAlex

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients

PaperCitations, authors & open-access status

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients is a paper indexed in PICO Portal from OpenAlex.

How many citations does Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients have?

PICO Portalcitation count

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients has 155 citations in the OpenAlex counts PICO Portal stores.

When was Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients published?

PICO Portalyear

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients has 2020 year in the PICO Portal index.

What is the open-access status of Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients?

PICO Portaloa status

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients has green oa status in the PICO Portal index.

What is the DOI of Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients?

PICO Portaldoi

The DOI for Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients is on the source record.

What is the PMID of Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients?

PICO Portalpmid

The PMID for Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients is on the source record.

What is the OpenAlex record for Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients?

PICO Portalopenalex

The OpenAlex for Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial